MELEAGROS SURGICAL LIMITEDActive

Company number 07222565Private limited companyIncorporated 2010

Key figures

£976,613+6.4%
Net assets 2024/25
+3.7%
Average annual growth 2019/20–2024/25
0250 k500 k750 k1 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, MELEAGROS SURGICAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand503,582508,342582,596594,107674,809
Total assets595,205569,123624,143970,8031,071,850
Total liabilities36,41833,27347,82147,08470,868
Net assets / total equity834,709808,838840,977918,079976,613
Average number of employees11120

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MELEAGROS SURGICAL LIMITED

Company

MELEAGROS SURGICAL LIMITED is a private limited company registered with Companies House under company number 07222565. It was incorporated on 13 Apr 2010. Its status is active. The registered office is in London (WC1H). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files small company accounts (filleted). Net assets were £976,613, up 6.4% on the previous year. Cash at bank and in hand was £674,809. Total assets were £1,071,850 and total liabilities £70,868. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 27 Apr 2027.